X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (21616) 21616
Book Review (4983) 4983
Publication (924) 924
Magazine Article (309) 309
Book / eBook (304) 304
Book Chapter (143) 143
Conference Proceeding (60) 60
Newsletter (60) 60
Newspaper Article (34) 34
Dissertation (14) 14
Trade Publication Article (7) 7
Web Resource (6) 6
Paper (4) 4
Patent (4) 4
Data Set (3) 3
Government Document (2) 2
Journal / eJournal (1) 1
Reference (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (16121) 16121
humans (15083) 15083
administration, oral (8069) 8069
female (7819) 7819
male (7481) 7481
warfarin (5201) 5201
aged (4963) 4963
anticoagulants - administration & dosage (4961) 4961
middle aged (4923) 4923
anticoagulants (4763) 4763
anticoagulants - therapeutic use (4576) 4576
adult (3895) 3895
atrial fibrillation (3559) 3559
risk factors (3496) 3496
anticoagulants - adverse effects (3406) 3406
hematology (3274) 3274
peripheral vascular disease (2899) 2899
stroke (2703) 2703
cardiac & cardiovascular systems (2655) 2655
treatment outcome (2645) 2645
oral anticoagulants (2618) 2618
pharmacology & pharmacy (2466) 2466
dabigatran (2425) 2425
abridged index medicus (2332) 2332
rivaroxaban (2248) 2248
aged, 80 and over (2236) 2236
thromboembolism (2135) 2135
venous thromboembolism (2134) 2134
animals (2132) 2132
atrial fibrillation - drug therapy (2112) 2112
risk (2070) 2070
prevention (2045) 2045
therapy (2034) 2034
management (1989) 1989
oral anticoagulation (1877) 1877
hemorrhage - chemically induced (1874) 1874
medicine, general & internal (1851) 1851
dentistry (1810) 1810
atrial-fibrillation (1765) 1765
surgery (1741) 1741
stroke - prevention & control (1707) 1707
international normalized ratio (1694) 1694
thrombosis (1648) 1648
analysis (1568) 1568
atrial fibrillation - complications (1558) 1558
warfarin - therapeutic use (1520) 1520
time factors (1492) 1492
anticoagulation (1489) 1489
dentistry, oral surgery & medicine (1484) 1484
care and treatment (1477) 1477
warfarin - administration & dosage (1440) 1440
retrospective studies (1389) 1389
medicine & public health (1388) 1388
apixaban (1352) 1352
oral anticoagulant-therapy (1206) 1206
warfarin - adverse effects (1202) 1202
drug therapy (1198) 1198
safety (1186) 1186
adolescent (1172) 1172
bleeding (1172) 1172
dose-response relationship, drug (1166) 1166
risk assessment (1153) 1153
thromboembolism - prevention & control (1150) 1150
stroke prevention (1127) 1127
health aspects (1126) 1126
prospective studies (1105) 1105
antithrombotic therapy (1075) 1075
deep-vein thrombosis (1053) 1053
patients (1047) 1047
blood coagulation - drug effects (1042) 1042
aspirin (1038) 1038
follow-up studies (1031) 1031
direct oral anticoagulants (1030) 1030
vitamin k - antagonists & inhibitors (1017) 1017
stroke - etiology (1009) 1009
hemorrhage (987) 987
pharmacokinetics (980) 980
mortality (963) 963
research (961) 961
molecular-weight heparin (926) 926
internal medicine (921) 921
rats (904) 904
cardiology (883) 883
cardiac arrhythmia (872) 872
anticoagulants - pharmacology (867) 867
risk-factors (846) 846
prothrombin time (845) 845
dosage and administration (831) 831
young adult (831) 831
metaanalysis (826) 826
drug interactions (812) 812
efficacy (793) 793
thrombin (791) 791
drug administration schedule (790) 790
clinical trials (760) 760
venous thrombosis (725) 725
medical research (721) 721
oral contraceptives (713) 713
randomized controlled trials as topic (679) 679
pregnancy (677) 677
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
UTL at Downsview - May be requested (158) 158
Dentistry (Harry R Abbott) - Stacks (81) 81
Gerstein Science - Stacks (51) 51
Dentistry (Harry R Abbott) - Withdrawn (50) 50
Dentistry (Harry R Abbott) - May be requested in 6-10 wks (33) 33
Collection Dvlpm't (Acquisitions) - Closed Orders (10) 10
Dentistry (Harry R Abbott) - Circulation Desk (7) 7
Online Resources - Online (7) 7
Collection Dvlpm't (Acquisitions) - Vendor file (6) 6
Dentistry (Harry R Abbott) - May be requested (5) 5
Dentistry (Harry R Abbott) - Searching (3) 3
Lakeridge Health Sciences - Oshawa (3) 3
Robarts - Stacks (3) 3
Scarborough Hospital - Birchmount (2) 2
St. Michael's Hospital - Stacks (2) 2
UofT at Mississauga - Stacks (2) 2
Chemistry (A D Allen) - Stacks (1) 1
Dentistry (Harry R Abbott) - Course Reserves (1) 1
Dentistry (Harry R Abbott) - Mending (1) 1
Dentistry (Harry R Abbott) - Missing (1) 1
Humber River Regional Hospital - Church Stacks (1) 1
New College (Ivey) - Stacks (1) 1
Regis College - Stacks (1) 1
Royal Ontario Museum - Reference (1) 1
Scarborough Hospital - General (1) 1
St Josephs Health Centre - Stacks (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
UTL at Downsview - Withdrawn (1) 1
University College (Laidlaw) - May be requested in 6-10 wks (1) 1
UofT at Scarborough - Stacks (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (20189) 20189
German (675) 675
French (423) 423
Spanish (405) 405
Italian (163) 163
Russian (137) 137
Japanese (90) 90
Portuguese (87) 87
Polish (72) 72
Hungarian (45) 45
Czech (20) 20
Danish (20) 20
Turkish (20) 20
Dutch (18) 18
Norwegian (15) 15
Chinese (14) 14
Swedish (14) 14
Korean (12) 12
Arabic (8) 8
Hebrew (8) 8
Bulgarian (6) 6
Finnish (6) 6
Serbian (6) 6
Croatian (5) 5
Slovenian (5) 5
Romanian (4) 4
Lithuanian (2) 2
Bosnian (1) 1
Estonian (1) 1
Georgian (1) 1
Icelandic (1) 1
Persian (1) 1
Welsh (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Heart Journal, ISSN 0002-8703, 2016, Volume 182, pp. 28 - 35
Background Non-vitamin K antagonist oral anticoagulants (NOACs, dabigatran, rivaroxaban, apixaban, and edoxaban) have been increasingly used as alternatives to... 
Cardiovascular | INTRAVENOUS THROMBOLYSIS | CARDIAC & CARDIOVASCULAR SYSTEMS | DABIGATRAN ANTICOAGULATION | TISSUE-PLASMINOGEN ACTIVATOR | WARFARIN | ACUTE ISCHEMIC-STROKE | GUIDELINES | INTRACEREBRAL HEMORRHAGE | RISK SCORE | HEALTH-CARE PROFESSIONALS | INTRACRANIAL HEMORRHAGE | United States - epidemiology | Dabigatran - adverse effects | Dabigatran - administration & dosage | Anticoagulants - administration & dosage | Humans | Stroke - diagnosis | Warfarin - adverse effects | Male | Thiazoles - administration & dosage | Antithrombins - administration & dosage | Medication Therapy Management - standards | Warfarin - administration & dosage | Rivaroxaban - administration & dosage | Thiazoles - adverse effects | Pyridones - administration & dosage | Pyridines - adverse effects | Rivaroxaban - adverse effects | Adult | Female | Registries | Stroke - therapy | Pyrazoles - adverse effects | Stroke - prevention & control | Pyridines - administration & dosage | Administration, Oral | Atrial Fibrillation - drug therapy | Atrial Fibrillation - complications | Emergency Treatment - methods | Anticoagulants - adverse effects | Outcome and Process Assessment (Health Care) | Pyrazoles - administration & dosage | Stroke - etiology | Quality Improvement | Antithrombins - adverse effects | Emergency Treatment - mortality | Pyridones - adverse effects | Cohort Studies | Stroke (Disease) | Warfarin | Diet therapy | Stroke patients | Atrial fibrillation | Index Medicus | Abridged Index Medicus
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 02/2008, Volume 51, Issue 8, pp. 818 - 825
Journal Article
1996, ISBN 0340552662, vii, 280
Book
American Journal of Medicine, The, ISSN 0002-9343, 2014, Volume 127, Issue 11, pp. 1075 - 1082.e1
Journal Article
American Journal of Medicine, The, ISSN 0002-9343, 2015, Volume 128, Issue 12, pp. 1300 - 1305.e2
Journal Article
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2017, Volume 69, Issue 23, pp. 2779 - 2790
Abstract Background Dose reduction of non–vitamin K antagonist oral anticoagulants (NOACs) is indicated in patients with atrial fibrillation (AF) with renal... 
Cardiovascular | Internal Medicine | kidney disease | dose | bleeding | embolism | stroke | CARDIAC & CARDIOVASCULAR SYSTEMS | SAFETY | RIVAROXABAN | RISK | APIXABAN | MDRD | CARE | COCKCROFT-GAULT | DABIGATRAN | WARFARIN | United States - epidemiology | Dabigatran - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Male | Antithrombins - administration & dosage | Rivaroxaban - administration & dosage | Factor Xa Inhibitors - administration & dosage | Incidence | Dose-Response Relationship, Drug | Young Adult | Pyridones - administration & dosage | Time Factors | Aged, 80 and over | Adult | Female | Renal Insufficiency - complications | Stroke - epidemiology | Retrospective Studies | Vitamin K | Stroke - prevention & control | Hemorrhage - epidemiology | Administration, Oral | Atrial Fibrillation - drug therapy | Atrial Fibrillation - complications | Treatment Outcome | Pyrazoles - administration & dosage | Stroke - etiology | Adolescent | Aged | Hemorrhage - chemically induced | Stroke (Disease) | Medical policy | Care and treatment | Atrial fibrillation | Health care industry | Anticoagulants (Medicine) | Kidney diseases | Medical research | Chronic kidney failure | Medicine, Experimental | Heart | Cardiac arrhythmia | Renal function | Embolisms | Indication | Impairment | Risk | Data bases | Bleeding | Training | Prevention | Confidence intervals | Fibrillation | Databases | Ischemia | Safety | Drug dosages | Anticoagulants | Dosing | Stroke | Statistical analysis | Regression | Hazards | Labels | Marking | Patients | Embolism | Disease prevention | Oral cavity | Renal failure | Clinical medicine | Kidney transplantation | Index Medicus | Abridged Index Medicus
Journal Article
American Heart Journal, ISSN 0002-8703, 2017, Volume 190, pp. 12 - 18
Background Oral anticoagulation prevents ischemic strokes in patients with atrial fibrillation. Early detection of atrial fibrillation and subsequent... 
Cardiovascular | FIBRILLATION | CARDIAC & CARDIOVASCULAR SYSTEMS | STROKE PREVENTION | WARFARIN | CLINICAL-IMPLICATIONS | AMERICAN-COLLEGE | CARDIAC MONITOR | RISK | OPEN-LABEL | TEMPORAL RELATIONSHIP | ISCHEMIC-STROKE | Prospective Studies | Follow-Up Studies | Humans | Male | Thiazoles - administration & dosage | Atrial Fibrillation - physiopathology | Aspirin - administration & dosage | Factor Xa Inhibitors - administration & dosage | Incidence | Time Factors | Female | Stroke - epidemiology | Vitamin K | Heart Rate | Stroke - prevention & control | Pyridines - administration & dosage | Survival Rate - trends | Double-Blind Method | Administration, Oral | Atrial Fibrillation - drug therapy | Risk Factors | Europe - epidemiology | Treatment Outcome | Disease-Free Survival | Stroke - etiology | Atrial Fibrillation - epidemiology | Aged | Fibrinolytic Agents - administration & dosage | Stroke (Disease) | Care and treatment | Anticoagulants (Medicine) | Stroke patients | Atrial fibrillation | Cardiac patients | Implants, Artificial | Prosthesis | Anticoagulants | Therapy | Cardiac arrhythmia | Surgical implants | Aspirin | Stroke | Coagulation | Strokes | Patients | Bleeding | Risk factors | Vitamins | Artifacts | Fibrillation | Ischemia | Defibrillators | Pacemakers | Safety engineering | Electrocardiography | Heart diseases | Index Medicus | Abridged Index Medicus | Trial Design
Journal Article